Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions
In the past years, several factors such as evidence-based healthcare culture, quality-linked incentives, and patient-centered actions, associated with an important increase of financial constraints and pressures on healthcare budgets, resulted in a growing interest by policy-makers in enlarging phar...
Main Authors: | Fernanda S. Tonin, Ignacio Aznar-Lou, Vasco M. Pontinha, Roberto Pontarolo, Fernando Fernandez-Llimos |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2021-03-01
|
Series: | Pharmacy Practice |
Subjects: | |
Online Access: | https://www.pharmacypractice.org/journal/index.php/pp/article/view/2302 |
Similar Items
-
PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING
by: M. V. Protsenko, et al.
Published: (2015-03-01) -
Medical, pharmaceutical, and biomedical applications of chitosan: A review
by: Rasha A F Jasim
Published: (2021-01-01) -
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
by: Maurilio de Souza Cazarim, et al.
Published: (2020-09-01) -
Pharmaceutical policies in Australia and New Zealand
by: Zaheer-Ud-Din Babar
Published: (2015-12-01) -
Commercializing successful biomedical technologies : basic principles for the development of drugs, diagnostics and devices /
by: 309421 Mehta, Shreefal S.
Published: (2008)